Posted by Michael Wonder on 31 Jul 2022
New Zealand Pharmaceutical Schedule - 1 August 2022
1 August 2022 - The August 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.
There is one new/revised listings of note this month - durvalumab (Imfinzi) for patients with non-small-cell lung cancer.
